ATE135914T1 - Aica riboside zur prophylaktischen behandlung von krankheiten mit einer verminderten durchblutung. - Google Patents

Aica riboside zur prophylaktischen behandlung von krankheiten mit einer verminderten durchblutung.

Info

Publication number
ATE135914T1
ATE135914T1 AT86902696T AT86902696T ATE135914T1 AT E135914 T1 ATE135914 T1 AT E135914T1 AT 86902696 T AT86902696 T AT 86902696T AT 86902696 T AT86902696 T AT 86902696T AT E135914 T1 ATE135914 T1 AT E135914T1
Authority
AT
Austria
Prior art keywords
blood circulation
prophylactic treatment
diseases involving
reduced blood
aica riboside
Prior art date
Application number
AT86902696T
Other languages
English (en)
Inventor
Harry Edward Gruber
Original Assignee
Gensia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gensia Inc filed Critical Gensia Inc
Application granted granted Critical
Publication of ATE135914T1 publication Critical patent/ATE135914T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT86902696T 1986-03-27 1986-04-08 Aica riboside zur prophylaktischen behandlung von krankheiten mit einer verminderten durchblutung. ATE135914T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84562786A 1986-03-27 1986-03-27

Publications (1)

Publication Number Publication Date
ATE135914T1 true ATE135914T1 (de) 1996-04-15

Family

ID=25295693

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86902696T ATE135914T1 (de) 1986-03-27 1986-04-08 Aica riboside zur prophylaktischen behandlung von krankheiten mit einer verminderten durchblutung.

Country Status (9)

Country Link
EP (2) EP0623348A1 (de)
JP (1) JP2509202B2 (de)
AT (1) ATE135914T1 (de)
AU (3) AU5668886A (de)
BR (1) BR8607124A (de)
DE (1) DE3650505T2 (de)
DK (1) DK175693B1 (de)
FI (1) FI875245A0 (de)
WO (1) WO1987005807A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells
ATE114474T1 (de) * 1989-01-24 1994-12-15 Gensia Pharma Verfahren und verbindungen zur verabreichung von aica ribosiden und zur erniedrigung des blutglucose gehaltes.
US5132291A (en) * 1989-01-24 1992-07-21 Gensia Pharmaceuticals, Inc. Antivirals and methods for increasing the antiviral activity of azt
IL103294A0 (en) * 1991-09-30 1993-05-13 Gensia Pharma Pharmaceutical compositions for preventing tissue damage associated with decreased blood flow
US5366960A (en) * 1993-08-26 1994-11-22 Warner-Lambert Company Method of treating cerebral and cardiovascular disorders employing [R]3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz 0-[4,5-d][1,3]diazepin-8-ol
EP1174141A3 (de) * 1996-01-23 2003-04-23 ICN Pharmaceuticals, Inc. Regulierung der TH1/TH2 Cytokinexpression durch Ribavirin and Ribavirinanaloge in activierten T-Lymphocyten
AU2026900A (en) * 1998-11-20 2000-06-13 Salk Institute For Biological Studies, The Neuron stimulation by ribavirin, and analogs thereof
US6680292B1 (en) 1998-11-20 2004-01-20 The Salk Institute For Biological Studies Pharmaceutical composition comprising ribavirin and growth factors and methods of use
KR20020023939A (ko) * 1999-01-29 2002-03-29 와트 씨 데이빗, 해리 에이 루스제 리바비린에 의해 면역 반응을 조절하는 방법
KR20030032908A (ko) * 1999-12-23 2003-04-26 아이씨엔 파마슈티컬스, 인코포레이티드 Ｌ-누클레오시드, ｌ-누클레오티드 및 이들의 유사체에대한 조성물 및 방법
WO2006105167A2 (en) 2005-03-28 2006-10-05 Pericor Therapeutics, Inc. Methods, compositions, and formulations for preventing or reducing adverse effects in a patient
AU2006339963B2 (en) * 2006-03-14 2010-02-25 Wholesome Biopharm Pty Ltd Method and composition for treating allergic diseases
US9492468B2 (en) 2008-10-03 2016-11-15 Pericor Therapeutics, Inc. Methods and compositions for treatment of acute heart failure

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US29835A (en) * 1860-08-28 Surveyor s instrument
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
USRE29835E (en) * 1971-06-01 1978-11-14 Icn Pharmaceuticals 1,2,4-Triazole nucleosides
US3888843A (en) * 1973-06-12 1975-06-10 Toyo Jozo Kk 4-carbamoyl-1-' -d-ribofuranosylimidazolium-5-olate
US3923785A (en) * 1974-04-22 1975-12-02 Parke Davis & Co (R)-3-(2-deoxy-{62 -D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo{8 4,5-d{9 {8 1,3{9 diazepin-8-ol
US4163839A (en) * 1977-12-09 1979-08-07 Zaidan Hojin Biselbutsu Kagaku Kenkyu Kai Isocoformycin and a process for the production thereof
GB2016452B (en) * 1978-02-18 1982-07-21 Kissei Pharmaceutical Imidazole compounds
JPS5671075A (en) * 1979-11-12 1981-06-13 Sumitomo Chem Co Ltd Novel imidazole derivative
EP0066909A3 (de) * 1981-05-15 1984-03-07 FISONS plc Imidazolderivate, deren pharmazeutische Zusammensetzungen und Verfahren zu deren Herstellung
JPS59167515A (ja) * 1983-03-15 1984-09-21 Ajinomoto Co Inc 免疫機能増強剤
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
JPH05334796A (ja) * 1992-06-02 1993-12-17 Sony Corp 光学式ディスク装置

Also Published As

Publication number Publication date
EP0262125A1 (de) 1988-04-06
DE3650505D1 (de) 1996-05-02
EP0262125B1 (de) 1996-03-27
JPS63503061A (ja) 1988-11-10
DK175693B1 (da) 2005-01-24
DK621487D0 (da) 1987-11-26
WO1987005807A1 (en) 1987-10-08
JP2509202B2 (ja) 1996-06-19
FI875245A (fi) 1987-11-27
AU5668886A (en) 1987-10-20
FI875245A0 (fi) 1987-11-27
AU6006090A (en) 1990-11-08
BR8607124A (pt) 1988-04-05
AU672243B2 (en) 1996-09-26
EP0623348A1 (de) 1994-11-09
DK621487A (da) 1988-01-26
AU5198693A (en) 1994-02-03
DE3650505T2 (de) 1996-09-19
EP0262125A4 (de) 1989-07-26

Similar Documents

Publication Publication Date Title
ATE258065T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
DE3777253D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
ATE135914T1 (de) Aica riboside zur prophylaktischen behandlung von krankheiten mit einer verminderten durchblutung.
DE3587266D1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
DE3684305D1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
DE3587741D1 (de) Behandlung von Hautkrankheiten.
DK254887A (da) Salve til behandling af hudsygdomme
PT86346A (en) Method of treatment by means of the 3:-deoxitimidinene-2:(3:deoxi-2:3:-didesidrotimidine) administration to animals of hot blood infected with retrovirus
DE3750934D1 (de) Behandlung von nicht-Akne-entzündlichen und -infektiösen Hautkrankheiten.
DE3778585D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
KR890001580A (ko) B형 간염 바이러스에 의해 유발되는 염증 질환을 치료하는 이중가닥 rna를 함유하는 약물
EP0376251A3 (en) An anticoagulant substance obtained from urine
DK586387D0 (da) Piperidinderivater til behandling af smertetilstande
EP0308197A3 (de) Verfahren zur Stimulierung des Immunsystems
DK0484340T3 (da) Behandling til nedsættelse af ødem ved hjerne- og muskelbeskadigelser
ATE44156T1 (de) Kovalent gebundener heparin-antithrombin iiikomplex, verfahren zu dessen herstellung und seine verwendung zur behandlung von thrombusembolie.
DE3778587D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
DE3780814D1 (de) Verwendung von nukleosiden zur herstellung eines medikamentes zur behandlung von krankheiten, die durch einen retrovirus oder den hepatitis-b-virus verursacht werden.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ATE30114T1 (de) Mittel zur pflege oder behandlung der menschlichen haut.
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DE3877102D1 (de) Methode fuer die behandlung von viraler gehirnentzuendung.
DE3668338D1 (de) Kontinuierliche behandlung von spannungslosem gewebe.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time